Human musculoskeletal system

TOM DENNINGER NAMED EXECUTIVE DIRECTOR OF THE INSTITUTE FOR MUSCULOSKELETAL ADVANCEMENT (iMSKA)

Retrieved on:

Wednesday, May 1, 2024

OCS, Quality, Drug, Innovation, DPT, Human musculoskeletal system, Doctor of Philosophy, Research, Development, Learning, Science, ATI Physical Therapy, MSK, Sacred Heart University, MBA, Growth, Nursing

BOLINGBROOK, Ill., May 1, 2024 /PRNewswire/ -- The Institute for Musculoskeletal Advancement (iMSKA) today appointed Tom Denninger, PT, DPT, OCS, FAAOMPT, as Executive Director. This is the first executive appointment by iMSKA, which announced its formation earlier this year. Mr. Denninger will play a pivotal role in shaping the strategy for equipping, training, and transforming MSK care delivery through research and post professional development.

Key Points:

Founded by ATI Physical Therapy, iMSKA will drive musculoskeletal research and post-secondary education in the field
BOLINGBROOK, Ill., May 1, 2024 /PRNewswire/ -- The Institute for Musculoskeletal Advancement ( iMSKA ) today appointed Tom Denninger, PT, DPT, OCS, FAAOMPT, as Executive Director.
Mr. Denninger will play a pivotal role in shaping the strategy for equipping, training, and transforming MSK care delivery through research and post professional development.
"iMSKA represents a commitment to advance scientific MSK research while providing resources and opportunities for practicing professionals," Mr. Denninger said.
Previously, Mr. Denninger was Senior Director of Learning and Development ATI Physical Therapy, where he oversaw all internal and external clinical education and development programs.

Enable Me Cites New Research by Siemens Healthineers Concluding Job-Related Physical Stresses and Strains for Radiologists Are Resulting in More Turnover and Fewer Entering the Profession

Retrieved on:

Wednesday, May 1, 2024

Health, Medical Devices, Health Technology, General Health, Radiology, Research, Science, Elbow, Siemens Healthineers, Female, Shoulder, Human musculoskeletal system, Patient, Wrist, Human, Peter Hancock (professor), Breast cancer, Nursing

Enable Me , a VELA Medical company, today cited major new research by Siemens Healthineers entitled, “The future of Mammography: 4 critical challenges,” which cites poor workplace ergonomics and physical stress and strains as among the chief reasons for high radiologist turnover and fewer graduates entering the profession.

Key Points:

Enable Me , a VELA Medical company, today cited major new research by Siemens Healthineers entitled, “The future of Mammography: 4 critical challenges,” which cites poor workplace ergonomics and physical stress and strains as among the chief reasons for high radiologist turnover and fewer graduates entering the profession.
“And because the patient is safely seated and stable, image accuracy can be improved.”
The Siemens researchers, based in Germany, wrote that turnover in the radiology profession is estimated at 17.5% annually.
“Administrators must confront the scarcity of qualified personnel alongside the growing demand for breast cancer screening services.
The study reported that repetitive movements adopted by the mammographer have been associated with work-related musculoskeletal disorders, resulting in long-term sickness.

Best Nomos, A TeamBest Global Company, Launches Its Most Modern, Highly Innovative Compact SONALIS Ultrasound System

Retrieved on:

Monday, April 29, 2024

Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS Ultrasound System .

Key Points:

Best Nomos, a TeamBest Global Company, is launching its most modern, highly innovative Compact SONALIS Ultrasound System .
With its previous hallmark, patented SimulView™ Technology, the system provides superior visualization of HDR, LDR, Tranperineal Biopsies, fiducial marker placements, or any other procedure that can be performed with a transrectal ultrasound system.
SimulView™ Technology provides simultaneous “live” views of the prostate in both planes, thereby increasing treatment accuracy and precision.
To see a video about Best Nomos's Compact Sonalis Ultrasound System, please go to http://www.teambest.com/videos/Best-nomos-Compact-Sonalis-1080p.mp4 .

Viewpoint with Dennis Quaid Partners with Kinotek® to Explore Technological Innovation in Musculoskeletal Health

Retrieved on:

Wednesday, March 27, 2024

Health, Organization, Partnership, Knowledge, Musculoskeletal injury, 3D, Chronic pain, Quality of life, Human musculoskeletal system, Pain, Multimedia, MSK, Movement, Map, Television

MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Viewpoint, the esteemed educational program hosted by actor Dennis Quaid, is thrilled to announce an upcoming collaboration with Kinotek for an episode dedicated to exploring technological innovation in musculoskeletal (MSK) health. This partnership underscores Viewpoint's commitment to providing viewers with informative and transformative content that highlights cutting-edge solutions to pressing health issues.

Key Points:

The educational program looks into the health sector...
MIAMI, March 27, 2024 /PRNewswire-PRWeb/ -- Viewpoint, the esteemed educational program hosted by actor Dennis Quaid, is thrilled to announce an upcoming collaboration with Kinotek for an episode dedicated to exploring technological innovation in musculoskeletal (MSK) health.
A representative of Viewpoint said, "We're excited to partner with Kinotek to explore the transformative potential of technology in musculoskeletal health.
As filming commences and preparations for distribution are underway, Viewpoint and Kinotek invite individuals and organizations to join the conversation and contribute to the ongoing dialogue surrounding musculoskeletal health and technological innovation.
Development Division, Viewpoint with host Dennis Quaid, 561-244-7620, [email protected] , www.viewpointproject.com
View original content to download multimedia: https://www.prweb.com/releases/viewpoint-with-dennis-quaid-partners-with...

ATI PHYSICAL THERAPY LAUNCHES THE INSTITUTE FOR MUSCULOSKELETAL ADVANCEMENT (iMSKA)

Retrieved on:

Tuesday, February 13, 2024

Senior, MSK, Human musculoskeletal system, Partnership, ATI Physical Therapy, Patient, Science, Publication, Research, Nursing

BOLINGBROOK, Ill., Feb. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United States, today announced the formation of The Institute for Musculoskeletal Advancement (iMSKA). iMSKA represents a commitment to advance scientific MSK research while providing resources and opportunities for practicing professionals.

Key Points:

iMSKA's purpose is to drive musculoskeletal research and advance post-secondary education in the field; applications for iMSKA fellowships and residencies forthcoming
BOLINGBROOK, Ill., Feb. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United States, today announced the formation of The Institute for Musculoskeletal Advancement (iMSKA).
In partnership with ATI Physical Therapy, iMSKA is dedicated to progressing quality clinical care with a focus on research.
Dr. Chuck Thigpen, Senior Vice President for Clinical Excellence for ATI Physical Therapy, said iMSKA will contribute and distribute research and thought leadership in the management of patients with musculoskeletal issues.
"iMSKA represents a commitment by ATI to promote the advancement of MSK care through scientific research, training and development," Dr. Thigpen said.

Nox Health Appoints Jonathan Fox as Chief Commercial Officer of its Enterprise Business

Retrieved on:

Wednesday, February 7, 2024

Sleep, Growth, Fortune 500, Human musculoskeletal system, Insomnia, Sleep apnea, Health, Trade

ALPHARETTA, Ga., Feb. 7, 2024 /PRNewswire/ -- Nox Health, a global leader in sleep diagnostics and value-based sleep care management, today announced the appointment of Jonathan Fox as Chief Commercial Officer of its Enterprise business. In this role, Jonathan will focus on expanding Nox Health's value-based sleep care management business in the U.S. benefits space, reframing sleep as a critical intervention strategy for chronic conditions.

Key Points:

ALPHARETTA, Ga., Feb. 7, 2024 /PRNewswire/ -- Nox Health , a global leader in sleep diagnostics and value-based sleep care management, today announced the appointment of Jonathan Fox as Chief Commercial Officer of its Enterprise business.
In this role, Jonathan will focus on expanding Nox Health's value-based sleep care management business in the U.S. benefits space, reframing sleep as a critical intervention strategy for chronic conditions.
His exceptional domain expertise and leadership capabilities will be an invaluable asset to Nox," said Sigurjon Kristjansson, CEO of Nox Health.
"Sleep is usually a missing but foundational gap in care, inextricably linked to the chronic conditions which drive plan sponsor and health plan costs," noted Jonathan Fox, Chief Commercial Officer of the Nox Health Enterprise business.

Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report

Retrieved on:

Sunday, January 14, 2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and providers to resolve system-wide challenges hindering positive patient pathways from primary settings through to recovery.

Key Points:

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and providers to resolve system-wide challenges hindering positive patient pathways from primary settings through to recovery.
The Economist Impact - Musculoskeletal Injuries in Australia Report outlines the growing number of meniscal injury (MI) and rotator cuff (RC) injuries in Australia.
We know that access to care is dwindling, as elective surgery queues are getting bigger, and pathways are inconsistent between different clinicians and providers.
And second, in their access to the new and enormous amounts of data that’s coming out in this area.”
Please see the report here: https://impact.economist.com/perspectives/health/musculoskeletal-injurie...
1.

National Safety Council Releases Inaugural MSD Pledge Community Report on Workplace Injury Progress

Retrieved on:

Wednesday, January 10, 2024

WASHINGTON, Jan. 10, 2024 /PRNewswire/ -- Musculoskeletal disorders, or MSDs, are the most common workplace injury, costing U.S. businesses in the private sector nearly $17 billion a year, according to the Liberty Mutual Workplace Safety Index. Recognizing the impact these injuries have on workers and businesses, the National Safety Council, with funding from Amazon (NASDAQ: AMZN), established the groundbreaking MSD Solutions Lab in 2021 to solve workplace MSDs. As a hallmark initiative of the lab, the MSD Pledge was launched in June 2022 and many of the world's leading employers have joined the global effort to reduce this pervasive safety challenge. To help monitor progress along this journey of transforming workplace safety and improving the lives of millions of workers, NSC developed the MSD Solutions Index, an annual benchmarking survey, and today released the inaugural findings in the MSD Solutions Index Pledge Community Report.

Key Points:

Recognizing the impact these injuries have on workers and businesses, the National Safety Council , with funding from Amazon (NASDAQ: AMZN), established the groundbreaking MSD Solutions Lab in 2021 to solve workplace MSDs.
To help monitor progress along this journey of transforming workplace safety and improving the lives of millions of workers, NSC developed the MSD Solutions Index, an annual benchmarking survey, and today released the inaugural findings in the MSD Solutions Index Pledge Community Report .
The MSD Solutions Index provides MSD Pledge members with individualized feedback on areas of success and opportunity for improvement related to their current MSD reduction efforts and to help identify broader industry trends impacting MSD prevention efforts.
Recently, the Council introduced the next evolution of its industry-first call-to-action to transform workplace safety, the MSD Pledge 2.0 .

AbelZeta Announces Formation of Scientific Advisory Board to Support Inflammatory and Immunological Diseases

Retrieved on:

Wednesday, January 3, 2024

These four industry experts are distinguished scientific leaders with vast experience in the autoimmune disease field."

Key Points:

These four industry experts are distinguished scientific leaders with vast experience in the autoimmune disease field."
Members of the SAB include:
Peter Lipsky, M.D., served on the Board of Directors of the American College of Rheumatology.
She was President of the American College of Rheumatology, President of the Henry Kunkel Society, and Chair of the Scientific Advisory Board of the Lupus Research Alliance.
"AbelZeta is advancing promising new therapies for inflammatory and immunological diseases through innovative cell therapy platforms that provide custom-tailored treatment for each individual patient.

OREF, MTEC, DOD Select Recipients of $2 Million Research Award Collaboration

Retrieved on:

Tuesday, October 24, 2023

ROSEMONT, Ill., Oct. 24, 2023 /PRNewswire-PRWeb/ -- The Orthopaedic Research and Education Foundation (OREF), in collaboration with the Medical Technology Enterprise Consortium (MTEC) and the Department of Defense's (DOD) U.S. Army Medical Research and Development Command's (USAMRDC) Military Operational Medicine Research Program (MOMRP), today announced selection for recipients of the OREF/MTEC Request for Project Proposals entitled, "MTEC-23-02-MSKI, Solutions to Accelerate Return-to-Readiness following Musculoskeletal Injuries." The program provides $2 million in research and development funding. OREF is contributing $100,000 toward the awards, which was made possible by a generous gift from The Aircast Foundation, a private foundation committed to promoting and supporting excellence in scientific and clinical research and education in the area of orthopaedic medicine. The remainder of the funding is provided by the DOD.

Key Points:

Recipients will utilize the funds for research leading to the advancement of solutions to accelerate return-to-readiness for Service Members experiencing musculoskeletal injuries.
The program provides $2 million in research and development funding.
OREF is excited to collaborate with MTEC and MOMRP to fund research that may accelerate return-to-readiness for Service members affected by musculoskeletal injuries."
"An important component of the public-private collaboration that MTEC fosters is the ability to leverage philanthropic dollars to serve military medical need.